Deepak Nitrite Ltd

Deepak Chem Tech, a wholly owned subsidiary of Deepak Nitrite has today issued and allotted 1,76,00,000 9% Optionally Convertible Redeemable Preference Shares ('OCRPS'), having face value of Rs 100 each, aggregating to Rs 176 crore to Deepak Phenotics (DPL), another wholly owned subsidiary of the Company. Powered by Capital Market - Live

On year on year (YoY) basis, the company's consolidated revenue jumped 2.5%, while net profit declined 20.3% in Q4 FY25. Profit before tax (PBT) declined 20.2% YoY but increased 106% QoQ to Rs 278.71 crore in Q4 FY25. EBITDA stood at Rs 339 crore, up 6% YoY compared with Rs 320 crore posted in corresponding quarter last year. The EBITDA margin remained steady at 15% in Q4 FY25 compared to Q4 FY24. On segmental front, the revenue from advanced intermediates was at Rs 654 crore (down 3% YoY) while revenue from phenolics stood at Rs 1,532 crore, (up 5%) during the period under review. On full year basis, the company's consolidated net profit declined 14% to Rs 697.24 crore on 7.8% increase in revenue from operations to Rs 8,281.93 crore in FY25 over FY24. Deepak C. Mehta, chairman & managing director said: 'With all projects coming in with entire backward and forward integration we would be poised for much more resilient operations with an improved bottom line performance. In these turbulent times backward and forward integration go a longway in ensuring that ultimate consumers are taken care of and both the commodity and specialty businesses support each other. Our growth plan envisages development of further upstream products like Nitric Acid and downstream products such as MIBK, MIBC, for which capacities are set to be operationalized in the upcoming quarters. These will deepen the degree of integration across our business and strengthen our competitive position. The plan to manufacture polycarbonate resins is also taking more concrete shape and the Board of DCTL has recently approved investments for manufacturing 300 KTA of Phenol, 185 KTA of Acetone and 100 KTA of lsopropyl Alcohol (lPA) including greenfield infrastructure capex for an aggregate investment of about 3,500 crore. This is over and above the present manufacturing capacity of these products and the new capacity of Phenol and Acetone will be ultimately integrated to produce Polycarbonate Resins. This approval along with the previous approval of 5,000 crore of PC resins brings the aggregate investment pipeline for the PC Resin project to around 8,500 crore. As already mentioned, Deepak will be one of the largest single location producers of Phenol and Acetone in the entire world with more than half of the capacity converted into downstream derivatives such as Bisphenol A and PC Resins, etc. With the commitment to increased Research and Development Activity the new R&D Centre is scheduled to be operative during the year. We are already bringing forward new projects that would enhance our position in life sciences business as well as specialty solvents. New Products in the area of Material Sciences are also being considered based on core competencies of Deepak.' Meanwhile, the company's board recommended a dividend of Rs 7.50 per share with a face value of Rs 2 per share for FY25, subject to approval of shareholders at ensuing annual general meeting (AGM. The dividend, if approved by shareholders at the ensuing 54th AGM of the company will be paid within 30 days from the date of AGM. Deepak Nitrite is a leading chemical intermediates producer with a diversified portfolio that caters to the dyes and pigments, agrochemical, pharmaceutical, plastics, textiles, paper and home and personal care segments. It also manufactures petrochemical-derived intermediates such as phenolics, acetone, and isopropyl alcohol (IPA) for both domestic and international markets.Powered by Capital Market - Live

Upcoming Results: Bajaj Auto, Landmark Cars, Lemon Tree Hotels, Mazagaon Dock Shipbuilders, Alkem Laboratories, Amara Raja Energy & Mobility, Mrs. Bectors Food Specialities, Campus Activewear, Century Plyboards (India), Concord Biotech, Confidence Petroleum India, Engineers India, Gujarat Pipavav Port, ICRA, IPCA Laboratories, JNK India, MNCC (India), Ola Electric Mobility, Prestige Estate Pojects, Suzlon Energy will declare their results later today. Stocks to Watch: Deepak Nitrite's consolidated net profit declined 20.3% to Rs 202.41 crore, despite a 2.5% jump in net sales to Rs 2,179.69 crore in Q4 FY25 over Q4 FY24. Insecticides (India) reported 84.7% jump in consolidated net profit to Rs 13.89 crore on 31.7% increase in net sales to Rs 358.92 crore in Q4 FY25 over Q4 FY24. Bata India's consolidated net profit fell 27.9% to Rs 45.92 crore on 1.2% fall in net sales to Rs 788.21 crore in Q4 FY24 over Q4 FY25 Welspun Corp's consolidated net profit surged 160.7% to Rs 698.31 crore, despite a 12% decline in net sales to Rs 3,924.97 crore in Q4 FY25 over Q4 FY24. Avanti Feeds reported a 45.8% increase in consolidated net profit to Rs 151.77 crore on 7.9% increase in net sales to Rs 1,385.14 crore in Q4 FY25 over Q4 FY24. Indian railway Catering Tourism Corporation (IRCTC)'s consolidated net profit jumped 26.1% to Rs 358.23 crore on 9.9% increase in net sales to Rs 1,268.53 crore in Q4 FY25 over Q4 FY24.Powered by Capital Market - Live

Net profit of Deepak Nitrite declined 20.27% to Rs 202.41 crore in the quarter ended March 2025 as against Rs 253.86 crore during the previous quarter ended March 2024. Sales rose 2.52% to Rs 2179.69 crore in the quarter ended March 2025 as against Rs 2126.21 crore during the previous quarter ended March 2024. For the full year,net profit declined 14.02% to Rs 697.24 crore in the year ended March 2025 as against Rs 810.90 crore during the previous year ended March 2024. Sales rose 7.81% to Rs 8281.93 crore in the year ended March 2025 as against Rs 7681.83 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales2179.692126.21 3 8281.937681.83 8 OPM %14.5214.16 -13.1814.62 - PBDT329.96315.85 4 1148.121187.59 -3 PBT278.71269.39 3 952.751021.93 -7 NP202.41253.86 -20 697.24810.90 -14 Powered by Capital Market - Live

Deepak Nitrite announced that the Board of Directors of the Company at its meeting held on 28 May 2025, inter alia, have recommended the final dividend of Rs 7.5 per equity Share (i.e. 375%) , subject to the approval of the shareholders.Powered by Capital Market - Live

Deepak Nitrite will hold a meeting of the Board of Directors of the Company on 28 May 2025.Powered by Capital Market - Live

Go Digit General Insurance Ltd, Concord Biotech Ltd, Natco Pharma Ltd, Kalpataru Projects International Ltd are among the other stocks to see a surge in volumes on NSE today, 14 February 2025.Deepak Nitrite Ltd registered volume of 52.19 lakh shares by 14:14 IST on NSE, a 33.39 fold spurt over two-week average daily volume of 1.56 lakh shares. The stock slipped 15.47% to Rs.1,891.90. Volumes stood at 1.92 lakh shares in the last session.Go Digit General Insurance Ltd witnessed volume of 133.74 lakh shares by 14:14 IST on NSE, a 24.96 times surge over two-week average daily volume of 5.36 lakh shares. The stock increased 1.33% to Rs.301.15. Volumes stood at 3.31 lakh shares in the last session.Concord Biotech Ltd recorded volume of 9.89 lakh shares by 14:14 IST on NSE, a 7.45 times surge over two-week average daily volume of 1.33 lakh shares. The stock lost 20.00% to Rs.1,689.40. Volumes stood at 60836 shares in the last session.Natco Pharma Ltd registered volume of 73.64 lakh shares by 14:14 IST on NSE, a 5.74 fold spurt over two-week average daily volume of 12.83 lakh shares. The stock slipped 9.05% to Rs.886.80. Volumes stood at 84.1 lakh shares in the last session.Kalpataru Projects International Ltd registered volume of 14.64 lakh shares by 14:14 IST on NSE, a 4.4 fold spurt over two-week average daily volume of 3.33 lakh shares. The stock slipped 11.26% to Rs.871.60. Volumes stood at 5.54 lakh shares in the last session.Powered by Capital Market - Live

Go Digit General Insurance Ltd, Anupam Rasayan India Ltd, Concord Biotech Ltd, Godfrey Phillips India Ltd are among the other stocks to see a surge in volumes on BSE today, 14 February 2025.Deepak Nitrite Ltd witnessed volume of 1.39 lakh shares by 10:48 IST on BSE, a 19.43 times surge over two-week average daily volume of 7148 shares. The stock dropped 14.32% to Rs.1,916.50. Volumes stood at 8175 shares in the last session.Go Digit General Insurance Ltd clocked volume of 2.61 lakh shares by 10:48 IST on BSE, a 8.9 times surge over two-week average daily volume of 29340 shares. The stock gained 3.55% to Rs.307.60. Volumes stood at 23395 shares in the last session.Anupam Rasayan India Ltd saw volume of 21856 shares by 10:48 IST on BSE, a 5.42 fold spurt over two-week average daily volume of 4030 shares. The stock increased 2.91% to Rs.691.00. Volumes stood at 3294 shares in the last session.Concord Biotech Ltd registered volume of 22155 shares by 10:48 IST on BSE, a 4.23 fold spurt over two-week average daily volume of 5232 shares. The stock slipped 10.56% to Rs.1,887.10. Volumes stood at 4819 shares in the last session.Godfrey Phillips India Ltd recorded volume of 78442 shares by 10:48 IST on BSE, a 3.75 times surge over two-week average daily volume of 20933 shares. The stock gained 15.59% to Rs.5,759.75. Volumes stood at 22183 shares in the last session.Powered by Capital Market - Live

Revenue from operation stood at Rs 1,903.40 crore in Q3 FY25, down 5.27%, compared with Rs 2,009.23 crore posted in Q3 FY24. Profit before tax in Q3 FY25 was at Rs 135.2 crore, down 50.58% as against Rs 273.59 crore reported in the same period a year ago. EBITDA for the third quarter of FY24 stood at Rs 190 crore, registering a decline of 40.25% compared to Rs 318 crore in Q3 FY23. EBITDA margin reduced to 10% in Q3 FY25, compared to 16% recorded in the corresponding quarter previous year. On the segmental front, the revenue from advanced intermediates was at Rs 551.69 crore (down 18.18% YoY), while revenue from phenolics stood at Rs 1,365.74 crore (up 1.22%) during the period under review. Deepak C. Mehta, chairman & managing director, said, 'Normally the business cycles of AI and phenolics are generally such that on an overall basis they complement each other. This is the first time we are experiencing both businesses going through short-term challenges. I am happy we have been able to achieve yet another milestone in phenol capacity utilization. Domestic production now more or less matches domestic demand, and as the market accepts the new normal, margins should improve. On the AI business segment, the world has been going through de-stocking in the agro-chem business. As an intermediate supplier, we have been impacted with a lag. As we see agrobusiness picking up again, it is a matter of time when our performance will be back to normal. New products in the group, including upstream products like nitric acid and downstream products like MIBK and MIBC, should be coming into operations in the next few months. In the meantime, our long-term plan for the polymer business is rapidly taking shape. Having entered into long-term agreements for pipeline supply of critical feedstock and contracted to acquire German assets for the final product, viz., polycarbonate resins, we are actively working to complete the entire value chain. India continues to import almost 300 kta of polycarbonate resin. Deepak will be producing about 160 kta in the first phase. All our projects are targeted to be completed by the end of FY2028. Overall, we remain committed to investing in strategic growth initiatives, including new product development and targeted market expansion, to ensure long-term value creation for our shareholders.' Deepak Nitrite produces a spectrum of chemicals, including agrochemicals, colorants, rubber, pharmaceuticals, specialties, and fine chemicals. The company manufactures chemical intermediates to serve the domestic and international markets with high-quality products made in a responsible and sustainable manner.Powered by Capital Market - Live

Net profit of Deepak Nitrite declined 51.45% to Rs 98.09 crore in the quarter ended December 2024 as against Rs 202.05 crore during the previous quarter ended December 2023. Sales declined 5.27% to Rs 1903.40 crore in the quarter ended December 2024 as against Rs 2009.23 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales1903.402009.23 -5 OPM %8.8515.16 - PBDT183.42315.28 -42 PBT135.20273.59 -51 NP98.09202.05 -51 Powered by Capital Market - Live